Prophylactic efficacy of some chemoprotectants against abrin induced lethality

Open access

Abstract

Abrin is a highly toxic protein produced by Abrus precatorius. Exposure to abrin, either through accident or by act of terrorism, poses a significant risk to human health and safety. Abrin functions as a ribosome-inactivating protein by depurinating the 28S rRNA and inhibits protein synthesis. It is a potent toxin warfare agent. There are no antidotes available for abrin intoxication. Supportive care is the only option for treatment of abrin exposure. It is becoming increasingly important to develop countermeasures for abrin by developing pre- and post-exposure therapy. The aim of this study is to screen certain pharmaceutical compounds for their chemoprotective properties against abrin toxicity in vivo in BALB/c male mice. Twenty-one compounds having either antioxidant, anti-inflammatory and cyto-protective properties or combination of them, were screened and administered as 1h pre-treatment followed by exposure of lethal dose (2×LD50, intraperitoneally) of abrin. To assess the protective efficacy of the compounds, survival and body weight was monitored. Fifteen compounds extended the survival time of animals significantly, as compared to abrin. The following five of these compounds, namely: Epicatechin-3-gallate, Gallic Acid, Lipoic Acid, GSH and Indomethacin extended the life time ranging from 6 to 9 days. These compounds also attenuated the abrin induced inflammation and enzymes associated with liver function, but none of them could prevent abrin induced lethality. The compounds offering extension of life could be useful to provide a time-window for other supportive treatment and could also be used as combinatorial therapy with other medical countermeasures against abrin induced lethality.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Bora N Gadadhar S Karande AA. (2010). Signaling different pathways of cell death: Abrin induced programmed necrosis in U266B1 cells. Int J Biochem Cell Biol 42: 1993–2003.

  • BTWC. (2001). BWC/AD HOC GROUP/56 from the 23rd Session of the Ad Hoc Group of States Parties to the Convention Geneva 23 April-11 May 2001.

  • Dickers KJ Bradberry SM Rice P Griffiths GD Vale JA. (2003). Abrin poisoning. Toxicol Rev 22: 137–42.

  • Dickey DT Muldoon LL Doolittle ND Peterson DR Kraemer DF Neuwelt EA. (2008). Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-inducedtoxicity in rat models. Cancer Chemother Pharmacol. 62: 235–41.

  • Endo Y Mitsui K Motizuki M Tsurugi K. (1987). The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262: 5908–12.

  • Gad SC Weil CS. (1989). Statistics for toxicologist In: Principles and methodology of Toxicology 2nd edition edited by AW Hyes. pp 435–83.Raven Press New York.

  • Garg V Hon YY Jusko WJ. (1994). Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats. Pharm Res 11: 541–4.

  • Griffiths GD. (2011). Understanding ricin from a defensive viewpoint. 3: 1373–92.

  • Kerksick C Willoughby D. (2005). The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 9: 38–44.

  • Kumar O Sugendran K Vijayaraghavan R. (2003). Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. Toxicon 41: 333–8.

  • Kumar O Kannoji A Jayaraj R Vijayaraghavan R. (2008). Purification and characterization of abrin toxin from white Abrus precatorius seeds. J Cell Tissue Res 8: 1243–1248.

  • Miller DJ Ravikumar K Shen H Suh JK Kerwin SM Robertus JD. (2002). Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition. J Med Chem 45: 90–8.

  • Muldoon DF Hassoun EA Stohs SJ. (1992). Ricin-induced hepatic lipid peroxidation glutathione depletion and DNA single-strand breaks in mice. Toxicon 30: 977–84.

  • Muldoon DF Stohs SJ. (1994). Modulation of ricin toxicity in mice by biologically active substances. J Appl Toxicol 14: 81–6.

  • Niyogi SK. (1977). Elevation of enzyme levels in serum due to Abrus precatorius (jequirity bean) poisoning. Toxicon 15: 577–80.

  • Ohkawa H Ohishi N Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–8.

  • Olsnes S Pihl A. (1973). Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibitinOlsnes S Pihl A. Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibiting protein synthesis. Biochemistry 12: 3121–6.

  • Olsnes S Sandvig K Eiklid K Pihl A. (1978). Properties and action mechnism of the toxic lectin modeccin: interaction with cell lines resistant to modeccin abrin and ricin. J Supramol Struct 9: 15–25.

  • Saxena N Rao PV Bhaskar AS Bhutia YD. (2014). Protective effects of certain pharmaceutical compounds against abrin induced cell death in Jurkat cell line. Int Immunopharmacol 21: 412–25.

  • Saxena N Yadav P Kumar O. (2013). The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci 135: 103–18.

  • Shih SF Wu YH Hung CH Yang HY Lin JY. (2001). Abrin triggers cell death by inactivating a thiol-specific antioxidant protein. J Biol Chem 276: 21870–21877.

  • Shalansky SJ Pate GE Levin A Webb JG. (2005). N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration. Heart 91: 997–999.

  • Singh BN Shankar S Srivastava RK. (2011). Green tea catechin epigallocatechin-3-gallate (EGCG): mechanisms perspectives and clinical applications. Biochem Pharmacol 82: 1807–21.

  • Sorrenti V Di Giacomo C Acquaviva R Barbagallo I Bognanno M Galvano F. (2013). Toxicity of ochratoxin and its modulation by antioxidants: a review. Toxins (Basel) 5: 1742–66.

  • Stirpe F Barbieri L Battelli MG Soria M Lappi DA. (1992). Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology (N Y) 10: 405–12.

  • Strickson S Campbell DG Emmerich CH Knebel A Plater L Ritorto MS et al. (2013). The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting theubiquitin system. Biochem J 451: 427–37.

  • Vijayaraghavan R Kumar P Joshi U Raza SK Lakshmana Rao PV Malhotra RC et al. (2001). Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity. Toxicology 163: 83–91.

  • Yuan L Betz JM Bindra JS Bobzin SC. (2012). Drug Discovery and Traditional Chinese Medicine: Science Regulation and Globalization. Springer Science & Business Media ISBN: 9780792374114.

  • Zou P Song J Jiang B Pei F Chen B Yang X et al. (2014). Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. Int J Clin Exp Pathol 7: 4607–16.

Search
Journal information
Impact Factor


CiteScore 2018: 1.78

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.671

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 126 126 8
PDF Downloads 89 89 9